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Intracardiac welding – a hot technology?
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Patent foramen ovale is a common finding
and has been shown to be a potential doorway for
thromboembolic lesions of the brain originating
from the venous system. Occasionally such mate-
rial, which usually ends up in the pulmonary cir-
culation [1], has been caught in the act of passing
through a patent foramen ovale [2]. Considering
the functional consequences of stroke, the recent
attempts to close potential doors in symptomatic
patients [3] with devices that also have other po-
tential applications [4] are logical steps forward.
However, technical difficulties (fig. 1) and the life-
long presence of foreign material within the car-
diac cavities which may induce device-specific
complications in the short and long run (throm-
bus buildup, infection, arrhythmia, migration,
erosion, fracture, etc) provide the setting for the
current keen interest in device-less alternatives. 
Various technologies have been developed for
implant-less interventions within the heart with-
out stopping it. This includes off-pump cardiac
repair (OPCARE), allowing intra-cardiac tailor-
ing and suturing with robotic assistance in the ex-
perimental setting [5, 6]. These and other studies
have shown that there are two main issues for suc-
cessful working-heart intracardiac repair, namely
visualisation and instrumentation. Although ap-
plication of thermal energy is well established for
the creation of lesion patterns, eg in the treatment
of atrial fibrillation. This approach has not so far
been used to weld mobile cardiac structures. In
contrast, cryotherapy has been proposed not only
for ablation of conducting tissue but also for tem-
porary sealing of cardiac perforations [7].
Initial clinical data on device-less closure
(welding) of atrial communications is reported by
Walpoth et al. in this issue [8]. For this purpose,
radiofrequency is applied to the two overlapping
borders of the patent foramen ovale which are
held together by a vacuum driven suction cup in
transcatheter fashion. The bonding mechanism
used in this setting is based on protein denatura-
tion by locally applied thermal energy (radio -
frequency). Although the preliminary results re-
ported are not a total success story, and the
 authors admit that there is a learning curve, the
technique described has major potential for the
applications presented and others. It may how-
ever be useful to recall some basic facts drawn
from industrial welding technologies. 
Welding of metals, for example, is an ex-
tremely sophisticated process requiring control of
many parameters. Welding of two components
made of steel is based on melting of both compo-
nents’ surfaces, with or without the use of addi-
tional melted material plus anti-oxydants etc. The
necessary energy can be brought to the welding
site from various sources. Oxyfuel is just one in-
teresting technical option because it can also be
used under water. For high output industrial
 production, however, an electric arc is more fre-
quently used, a technology that is also used in
melting scrap in steel mills. A more sophisticated
technology is the recent development of laser
welding, which in turn can be used to focus en-
ergy very precisely and may also have potential
for intravascular application, ie in conjunction
with a transparent optical carrier such as a water
jet.
Spot-welding is the industrial technology
which comes closest to the device-less foramen
ovale closure presented in this issue. As a matter
of fact, industrial spot-welding is not only carried
out with localised highly focused energy, but is
also known to require close approximation of the
two metal or plastic parts needing to be joined.
This industrial reality is related to the fact that no
additional melted material is added, and may ex-
plain why the reported clinical application of this
concept through temporary suction for position-
Figure 1
Endoscopic view of a
displaced atrial septal
occluder (Amplatzer)
with both lips in the
right atrium (bottom)
during surgical re-
moval through a right
mini-thoracotomy
with subsequent
 suture repair. 
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ing has not always been successful. The weakness
of the reported device-less closure of the foramen
ovale may indeed be lack of approximation, which
in turn may be the result of inadequate visualisa-
tion [6]. It can be expected that improved and
proven approximation (eg by 4D-echocardiogra-
phy) of the overlapping borders of the foramen
ovale prior to energy application will also yield
better outcomes for this and other clinical weld-
ing procedures.
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